| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/21/2001 | WO2000078972A8 Regulation with binding cassette transporter protein abc1 |
| 06/21/2001 | WO2000055345A9 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 06/21/2001 | WO1998011243A9 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 06/21/2001 | US20010004638 Enriched platelet wound healant |
| 06/21/2001 | CA2394801A1 Regenerative adjuvant |
| 06/21/2001 | CA2394798A1 Regenerative adjuvant (3-way tap) |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394012A1 Combination of ginseng and ginkgo to improve cognitive skills |
| 06/21/2001 | CA2393333A1 Compositions and methods for caspase-induced apoptosis |
| 06/21/2001 | CA2392137A1 Method for enhancing immune responses in mammals |
| 06/21/2001 | CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | CA2316671A1 Nutritional products and method for treating and preventing cancer and other degenerative diseases |
| 06/20/2001 | EP1108787A2 Production of vaccines |
| 06/20/2001 | EP1108738A2 Immunostimulating carrier for vaccines |
| 06/20/2001 | EP1108051A2 Inducible expression system |
| 06/20/2001 | EP1108048A1 Cationic complexes of polymer-modified adenovirus |
| 06/20/2001 | EP1108047A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/20/2001 | EP1108035A2 Treatment of cervical cancer |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1107796A2 Cells expressing immunoregulatory molecules and uses therefor |
| 06/20/2001 | EP1107794A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | EP1107784A2 Activation and protection of t-cells (cd4?+ and cd8?+ ) using an h 2? receptor agonist and other t-cell activating agents |
| 06/20/2001 | EP1107772A2 Probiotic, lactic acid-producing bacteria and uses thereof |
| 06/20/2001 | EP1107771A1 Homeopathic medicine comprising one or several mother-of-pearl constituents including bio-aragonite |
| 06/20/2001 | EP1107770A2 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 06/20/2001 | EP1107769A2 Method for inducing a donor tolerance in the human body |
| 06/20/2001 | EP1107768A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| 06/20/2001 | EP1107746A2 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 06/20/2001 | EP0815253B1 Multi-factor immunity modulator mixture, process for its production and medicaments containing said modulators |
| 06/20/2001 | EP0694304B1 An extract of freshwater mussel, methods of the extraction and uses thereof |
| 06/20/2001 | CN1300294A Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B and their use |
| 06/20/2001 | CN1300233A Method and apparatus for producing platelet rich plasma and/or platelet |
| 06/20/2001 | CN1300187A Dietary supplement derived from fermented milks for the prevention of osteoporosis |
| 06/20/2001 | CN1299681A Compound poultry lymphatic factor and its production process |
| 06/20/2001 | CN1299675A Gargle for treating toothache |
| 06/20/2001 | CN1299672A Preparation of hemiplegia treating capsule |
| 06/20/2001 | CN1299671A Toad skin mixture for treating hepatitis B |
| 06/20/2001 | CN1299665A Shuangqi granule for protecting lungs and eliminating allergy |
| 06/20/2001 | CN1299664A Common peganum herb oral liquid |
| 06/20/2001 | CN1299663A Diabetes treating medicine |
| 06/20/2001 | CN1299662A Diabetes treating medicine |
| 06/20/2001 | CN1299655A Hepatitis treating medicine |
| 06/20/2001 | CN1299654A Alopecia preventing and treating trichogen |
| 06/20/2001 | CN1299653A Naomaisu medicine |
| 06/20/2001 | CN1299649A External-use medicine for dermatosis and its preparation |
| 06/20/2001 | CN1299648A Hydrolytic nucleic acid solution |
| 06/20/2001 | CN1067460C Pumping device |
| 06/20/2001 | CN1067273C Pearl oropharyngeal powder |
| 06/20/2001 | CN1067272C Powder for curing gastric ulcer |
| 06/20/2001 | CN1067271C Capsule for curing hepatitis B |
| 06/20/2001 | CN1067270C Nutritions health care medicine |
| 06/20/2001 | CN1067267C Medicine for treating hepatitis B |
| 06/20/2001 | CN1067265C Medicine for treating trigeminal neuralgia |
| 06/20/2001 | CN1067264C Medicinal patch for treatment of cough and asthma |
| 06/20/2001 | CN1067263C Xiaoaisan powder for curing cancer |
| 06/20/2001 | CN1067259C Burns curing cream |
| 06/20/2001 | CN1067257C Drug for treating lupus erythematosus and preparation method |
| 06/20/2001 | CN1067254C Medicine for curing coronary heart disease and production technology |
| 06/20/2001 | CN1067250C Neutral calcium-supplementary preparation |
| 06/20/2001 | CN1067249C Medicine for treating asthma and its preparation method |
| 06/20/2001 | CN1067248C Pearl oyster preparation for supplement of calcium |
| 06/20/2001 | CN1067243C Medicinal Preparation for curing angiocardiopath |
| 06/20/2001 | CN1067223C Lactose-containing food composition for infants |
| 06/19/2001 | US6248791 Stimulating the differentiation of preadipocytic cells and therapies based thereon |
| 06/19/2001 | US6248587 Contacting cells with angiotensin/angiotensinogen derivative of specific amino acid sequence |
| 06/19/2001 | US6248557 RatC |
| 06/19/2001 | US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors |
| 06/19/2001 | US6248367 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
| 06/19/2001 | US6248366 Liquid colostrum for dairy products |
| 06/19/2001 | US6248341 Method of treating topical angiogenesis-related disorders |
| 06/19/2001 | US6248320 Herpes simplex virus; genetic engineering |
| 06/19/2001 | US6248238 Semipermeable membrane consisting of a negatively surface-charged electronegative polymer having adsorbed thereon before sterilization a cationic protease inhibitor to prevent kallikrein-kinin activation during dialysis |
| 06/19/2001 | CA2172187C Method of incorporating drugs into a polymer component of stents |
| 06/14/2001 | WO2001042789A1 MARKERS FOR IDENTIFICATION AND ISOLATION OF PANCREATIC ISLET α AND β CELL PROGENITORS |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042461A2 Apoptin-associating protein |
| 06/14/2001 | WO2001042449A2 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | WO2001042444A2 Methods for expression of genes in primates |
| 06/14/2001 | WO2001042428A1 Method for production of a skin graft and the graft produced thereby |
| 06/14/2001 | WO2001042425A2 Lung stem cells and lung regeneration |
| 06/14/2001 | WO2001042421A2 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 06/14/2001 | WO2001042263A2 Oligosaccharide mixture |
| 06/14/2001 | WO2001041809A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 06/14/2001 | WO2001041801A2 Mutant simplex virus for treating unwanted hyperproliferative cell growth |
| 06/14/2001 | WO2001041788A1 INDUCING CELLULAR IMMUNE RESPONSES TO p53 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 06/14/2001 | WO2001041776A2 Use of honey in medical dressings |
| 06/14/2001 | WO2001041775A2 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
| 06/14/2001 | WO2001017537A3 Methods and compositions for reducing immune response |
| 06/14/2001 | WO2001000829A8 Human endogenous retrovirus in breast cancer |
| 06/14/2001 | WO2000032631A3 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/14/2001 | US20010003585 Introducing a viral expression vector having a tumoricidal or susceptibility gene into a mammalian cell and attaching the cell to a support matrix in vitro; transferring the supported cells to mammalian tumor cells; durability; brains |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2393859A1 Apoptin-associating protein |
| 06/14/2001 | CA2393662A1 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393071A1 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 06/14/2001 | CA2392299A1 Methods for expression of genes in primates |
| 06/14/2001 | CA2383001A1 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | CA2361563A1 Use of polyacrylamide gel for forming a connective-tissue capsule in a mammal for cultivating allogenic or xenogenic cells |
| 06/13/2001 | EP1106620A2 Method for obtaining components from cultured leucocytes |